Home › Funds › Arlington Financial Advisors, LLC › GILD
Arlington Financial Advisors, LLC position in GILD
GILEAD SCIENCES INC · Health Care
Arlington Financial Advisors, LLC reported holding 42,024 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 0.79% of its reported portfolio and ranking #32 among its reported holdings. Arlington Financial Advisors, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How Arlington Financial Advisors, LLC's GILD position evolved
Arlington Financial Advisors, LLC first disclosed a stake in GILD in Q3 2023 at 43,084 shares (US$3.2M). The position peaked in Q3 2026 at 42,024 shares, worth US$6.3M. Across 13 filings, Arlington Financial Advisors, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 42,024 shares valued at US$6.3M — a reduction of -1,408 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 43.08K | $3.23M | New |
| Q4 2023 | 43.12K | $3.49M | Hold |
| Q1 2024 | 44.80K | $3.28M | Add |
| Q2 2024 | 46.04K | $3.16M | Add |
| Q3 2024 | 46.10K | $3.87M | Hold |
| Q4 2024 | 47.02K | $4.34M | Add |
| Q1 2025 | 46.54K | $5.21M | Reduce |
| Q2 2025 | 43.99K | $4.88M | Reduce |
| Q3 2025 | 44.73K | $4.97M | Add |
| Q4 2025 | 45.12K | $5.54M | Add |
| Q1 2026 | 43.74K | $6.10M | Reduce |
| Q2 2026 | 43.43K | $5.49M | Reduce |
| Q3 2026 | 42.02K | $6.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Arlington Financial Advisors, LLC
FAQ
How long has Arlington Financial Advisors, LLC held GILD?
Arlington Financial Advisors, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Arlington Financial Advisors, LLC's current position in GILD?
As of Q3 2026, Arlington Financial Advisors, LLC holds 42.02K shares of GILD (GILEAD SCIENCES INC), valued at $6.26M, representing 0.79% of its reported portfolio and ranking #32.
Has Arlington Financial Advisors, LLC been buying or selling GILD?
In the latest 13F filing (Q3 2026), Arlington Financial Advisors, LLC reduced its position in GILD. The position peaked in Q3 2026 at 42.02K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.